Med Ed Report briefs: January 2014

Share this article:
Eric Peterson
Eric Peterson

CME should not be industry supported, said Pew Charitable Trust as part of a 15-point conflict-of-interest proposal to ban or severely restrict interactions with industry. Proponents of physician education reacted negatively to Pew's report. The CME Coalition cited an absence of data that commercial support manifests any negative impact on outcomes.

Haymarket Medical Education won the award for outstanding collaboration from the Alliance for CE in the Health Professions. HME worked with Presbyterian Novant Heart & Wellness and data analysis firm Intelligent Medical Decisions on the type 2 diabetes activity. (Haymarket Media publishes MM&M.)

Eric Peterson, EdM, FACEHP, CCMEP, joined the American Academy of Physician Assistants as senior director, performance improvement CME. He was formerly VP, educational strategy and grant development for Annenberg Center for Health Sciences at Eisenhower Medical Center.

Physicians Interactive is expanding its CME content partnership with Oakstone Publishing, firms said, granting PI's Skyscape digital and mobile subscribers access to multimedia resources from Oakstone, an accredited med-ed provider.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?